Interestingly, recovery from COVID‐19 does not appear to substantially increase the abundance of iCope‐reactive CD4+ T cells (Figure 2C), yet these cells have been shown to be engaged early during infection and vaccination with beneficial effects [18]. This evidence concerns the gene CD4 and infection.